CAS: 957065-93-9 - 2-(3-Bromophenyl)-5-(2-thienyl)-1,3,4-oxadiazole
Fórmula:C12H7BrN2OS
InChI:InChI=1S/C12H7BrN2OS/c13-9-4-1-3-8(7-9)11-14-15-12(16-11)10-5-2-6-17-10/h1-7H
Chave InChI:InChIKey=JVUJDTWUKFHVDP-UHFFFAOYSA-N
SMILES:BrC1=CC=CC(=C1)C2=NN=C(O2)C=3SC=CC3
- Sinónimos:
- 1,3,4-Oxadiazole, 2-(3-bromophenyl)-5-(2-thienyl)-
- 2-(3-Bromophenyl)-5-(2-Thienyl)-1,3,4-Oxadiazole
- 2-(3-Bromophenyl)-5-(Thiophen-2-Yl)-1,3,4-Oxadiazole
| Marca | Dados do produto | Pureza | Gama de preços | Estimativa de entrega |
|---|---|---|---|---|
 | 2-(3-bromophenyl)-5-(thiophen-2-yl)-1,3,4-oxadiazole REF: IN-DA003ETCCAS: 957065-93-9 | - - - | A consultar | Ter 10 Dez 24 |
 | 2-(3-Bromophenyl)-5-(thien-2-yl)-1,3,4-oxadiazole REF: 54-OR59326CAS: 957065-93-9 | - - - | A consultar | Ter 17 Dez 24 |
 | 2-(3-Bromophenyl)-5-(thien-2-yl)-1,3,4-oxadiazole REF: 3D-HNB06593CAS: 957065-93-9 | Min. 95% | A consultar | Ter 21 Jan 25 |
 | 2-(3-Bromophenyl)-5-(thiophen-2-yl)-1,3,4-oxadiazole REF: 10-F213208CAS: 957065-93-9 | 95.0% | - - - | Produto descontinuado |
2-(3-bromophenyl)-5-(thiophen-2-yl)-1,3,4-oxadiazole
CAS:957065-93-9
Fórmula:
C12H7BrN2OS
Peso molecular:
307.1658
Ref: IN-DA003ETC
| Tamanho indefinido | A consultar |
Entrega estimada em Estados Unidos, Terça-feira 10 de Dezembro de 2024
Ref: 54-OR59326
| Tamanho indefinido | A consultar |
Entrega estimada em Estados Unidos, Terça-feira 17 de Dezembro de 2024
2-(3-Bromophenyl)-5-(thien-2-yl)-1,3,4-oxadiazole
CAS:957065-93-9
Please enquire for more information about 2-(3-Bromophenyl)-5-(thien-2-yl)-1,3,4-oxadiazole including the price, delivery time and more detailed …
Fórmula:
C12H7BrN2OS
Pureza:
Min. 95%
Peso molecular:
307.17 g/mol
Ref: 3D-HNB06593
| 5g | A consultar | ||
| 10g | A consultar |
Entrega estimada em Estados Unidos, Terça-feira 21 de Janeiro de 2025
2-(3-Bromophenyl)-5-(thiophen-2-yl)-1,3,4-oxadiazole
CAS:957065-93-9
Pureza:
95.0%
Peso molecular:
307.1700134277344
Ref: 10-F213208
| 1g | Descontinuado | Solicitar informações | |
| 5g | Descontinuado | Solicitar informações |
